Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192482-21-000463
Filing Date
2021-05-27
Accepted
2021-05-27 16:07:58
Documents
1
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 12622
  Complete submission text file 0001192482-21-000463.txt   14038
Mailing Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 263 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Issuer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 114 MILTON AVENUE CHAPEL HILL NC 27514
Business Address
Fernandes Prabhavathi (Reporting) CIK: 0001540883 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36751 | Film No.: 21972709